Loading...
Cytarabine — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Cytarabine
2025-Q4
Comprehensive analysis of India’s cytarabine export trade — suppliers, buyers, prices, routes, and every shipment record.
239
Shipments
$1.30M
Trade Value
42
Suppliers
51
Buyers
49
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/cytarabine
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s cytarabine trade — 2025-Q4
KEY TAKEAWAY
Cytarabine 2025-Q4 exports total $1.3M across 49 countries, with INTAS PHARMACEUTICALS LTD commanding 48.1% market share.
TOTAL SHIPMENTS
239
2025-Q4
EXPORT VALUE
$1.3M
FOB USD
TOTAL QUANTITY
228.8K
units shipped
INDIAN SUPPLIERS
42
unique exporters
GLOBAL BUYERS
51
unique importers
DESTINATIONS
49
countries
MEDIAN UNIT PRICE
$4.61
per unit
TOP-5 SHARE
94.1%
of total USD
BRANDED SHARE
51.9%
124 shipments
DOSAGE FORMS
5
product types
6 KEY FINDINGS
1
INTAS PHARMACEUTICALS LTD is India's #1 Cytarabine exporter with $625.0K (48.1% market share).→ §5, Indian Supplier Rankings
2
Cytarabine reached 49 countries, with South Africa as the top destination ($366.7K).→ §4, Global Destination Map
3
Market concentration is high (HHI: 3900) — top 10 suppliers control 97.5% of exports.→ §5, Indian Supplier Rankings
4
94.1% of buyers (48 of 51) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Injection dominates (81.9%) across 5 dosage forms.→ §7, Price Benchmarks
6
49 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 INTAS PHARMACEUTICALS LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian cytarabine exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Cytarabine report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial cytarabine trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian cytarabine suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Cytarabine India trade report
Product scope
Cytarabine
All variants merged — branded and generic formulations of cytarabine
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
239
Every commercial cytarabine trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $419.2K, Nov $690.5K, Dec $189.1K. Shipment counts were mixed across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$419.2K
Oct USD
83 shipments
2
$690.5K
Nov USD
+64.7% MoM
3
$189.1K
Dec USD
-72.6% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 64.7% in USD but shipment count kept steady.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $419K, making it the middle month by value.
Fig 3.2 Q4 cumulative USD reached $1.3M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $271K rise in Nov, $501K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $419K | 83 shipments |
| Nov | $690K | 81 shipments |
| Dec | $189K | 75 shipments |
| Q4 Total | $1.3M | 239 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: United Kingdom held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: INTAS PHARMACEUTICALS LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import cytarabine from India, how much they buy, and who supplies each market
KEY TAKEAWAY
South Africa absorbs 28.2% of India’s 2025-Q4 cytarabine trade ($366.7K). Beyond the top 10 destinations, 49 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Asia has 16 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 49 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much cytarabine India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$191K
14.7% of trade
16 countries · 64 shipments
Europe
$665K
51.2% of trade
13 countries · 132 shipments
Americas
$66K
5.1% of trade
6 countries · 8 shipments
Africa
$376K
29.0% of trade
14 countries · 35 shipments
Fig 4.1 South Africa is the #1 corridor ($367K) — 30 flow arcs from India radiate across 4 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian cytarabine it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | South Africa | $367K | 5 | FRESENIUS KABI ONCOLOGY LTD | $367K | — | — | — | — |
| 2 | Netherlands | $160K | 32 | INTAS PHARMACEUTICALS LTD | $160K | — | — | — | — |
| 3 | United Kingdom | $148K | 16 | INTAS PHARMACEUTICALS LTD | $148K | — | — | — | — |
| 4 | Poland | $88K | 16 | INTAS PHARMACEUTICALS LTD | $88K | — | — | — | — |
| 5 | France | $79K | 4 | INTAS PHARMACEUTICALS LTD | $79K | — | — | — | — |
| 6 | Germany | $62K | 3 | FRESENIUS KABI ONCOLOGY LTD | $62K | — | — | — | — |
| 7 | Malaysia | $58K | 1 | FRESENIUS KABI ONCOLOGY LTD | $58K | — | — | — | — |
| 8 | Austria | $52K | 8 | INTAS PHARMACEUTICALS LTD | $52K | — | — | — | — |
| 9 | Greece | $48K | 24 | INTAS PHARMACEUTICALS LTD | $48K | — | — | — | — |
| 10 | Brazil | $41K | 1 | INTAS PHARMACEUTICALS LTD | $41K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 14.7% of USD — but South Africa is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
28.2%
#1 country share
South Africa alone
64.8%
Top 5 share
5 of 49 countries
92.9%
Top 15 share
Long tail of 34 countries = 7.1%
HHI 1261
Destination HHI
Competitive spread
49
Countries served
Global pharma reach from India
16
Asia countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
42 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
INTAS PHARMACEUTICALS LTD ($625.0K, 48.1% share) and FRESENIUS KABI ONCOLOGY LTD ($513.9K) together control 87.7% of India’s 2025-Q4 cytarabine trade. The top 5 suppliers hold 94.1%. 42 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian cytarabine suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 INTAS PHARMACEUTICALS LTD leads by $111K over FRESENIUS KABI ONCOLOGY LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: HEET HEALTHCARE PVT is #14 by value but #5 by volume.
Fig 5.2 INTAS PHARMACEUTICALS LTD also leads by shipment count (126) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: HEET HEALTHCARE PVT moves from #5 by volume to #14 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 42 cytarabine suppliers split into strategic segments
KEY TAKEAWAY
11 suppliers (25%) generate 97.8% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 INTAS PHARMACEUTICALS LTD and FRESENIUS KABI ONCOLOGY LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 97.8% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LTD | 2 | 10 | $625K |
| 2 | FRESENIUS KABI ONCOLOGY LTD | 2 | 6 | $514K |
| 3 | UNITED BIOTECH PVT LTD | 1 | 4 | $40K |
| 4 | GLS PHARMA LTD | 1 | 1 | $23K |
| 5 | NAPROD LIFE SCIENCES PVT LTD | 1 | 2 | $21K |
| 6 | ZIL PHARMA | 1 | 1 | $13K |
| 7 | CELON LABORATORIES PVT LTD | 1 | 1 | $9K |
| 8 | RUS MED EXPORTS PVT LTD | 1 | 1 | $8K |
| 9 | GETWELL PHARMA INDIA PVT LTD | 1 | 2 | $7K |
| 10 | ZUVIUS LIFESCIENCES PVT LTD | 1 | 2 | $6K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the cytarabine manufacturing hubs
KEY TAKEAWAY
Ahmedabad and New Delhi together account for $1.2M of India’s 2025-Q4 cytarabine trade.
Fig 5.5 Ahmedabad (6 exporters, $616K) and New Delhi (2 exporters, $542K) are India’s cytarabine capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
94.1%
Top 5 share
5 of 42 suppliers
97.5%
Top 10 share
10 of 42 suppliers
97.8%
Top 25% share
11 suppliers = 98% USD
HHI 3900
Supplier HHI
Concentrated
42
Total suppliers
shipped Cytarabine in 2025-Q4
20+ cities
Indian hubs
Ahmedabad and New Delhi lead
§5.2 Coming next: 4 exporter deep-dive profiles
Each of the top 4 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | INTAS PHARMACEUTICALS LTD | $625K |
| #2 | FRESENIUS KABI ONCOLOGY LTD | $514K |
| #3 | UNITED BIOTECH PVT LTD | $40K |
| #4 | ZUVIUS LIFESCIENCES PVT LTD | $6K |
#1
EXPORTER PROFILE #1 OF 4
INTAS PHARMACEUTICALS LTD
Ahmedabad · India’s #1 cytarabine supplier by USD · 2025-Q4
2025-Q4 USD
$625K
48.1% market share
SHIPMENTS
126
avg $5K/ship
COUNTRIES
10
destination markets
BUYERS
12
9 single-sourced
BRANDED
39%
of shipments
DOSAGE FORMS
2
product types
TOP 10 DESTINATIONS
Netherlands is the #1 market at $160K (26% of trade), followed by United Kingdom at $148K. 10 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Netherlands | $160K | 32 | 25.6% |
| 2 | United Kingdom | $148K | 16 | 23.7% |
| 3 | Poland | $88K | 16 | 14.1% |
| 4 | France | $79K | 4 | 12.6% |
| 5 | Austria | $52K | 8 | 8.3% |
| 6 | Greece | $48K | 24 | 7.6% |
| 7 | Brazil | $41K | 1 | 6.5% |
| 8 | Spain | $8K | 2 | 1.2% |
| 9 | Malta | $2K | 16 | 0.3% |
| 10 | Hungary | $164 | 7 | 0.0% |
MONTHLY TREND
Oct peaked at $377K. Nov was the weakest at $123K.
PRODUCT MIX
Injection dominates at 96% of trade. Solution (3.5%) and Unknown are secondary formulations.
TOP BUYERS · 9/10 LOCKED IN
9 of 10 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Netherlands | $492K | N/A |
| BROCACEF NL:LOCAL | Netherlands | $47K | ⚠ Locked |
| BROCACEF NL:EU HUB | Netherlands | $37K | ⚠ Locked |
| Undisclosed buyer | Netherlands | $19K | N/A |
| ACCORD HEALTHCARE SING… | Greece | $15K | ⚠ Locked |
| ACCORD UK | United Kingdom | $8K | ⚠ Locked |
| ACCORD HEALTHCARE, SLU | Spain | $8K | ⚠ Locked |
| BROCACEF NL : LOCAL | Netherlands | $142 | ⚠ Locked |
| EUROFINS BIOPHARMA PRO… | Hungary | $113 | 2 sup. |
| BROCACEF NL : EU HUB | Netherlands | $105 | ⚠ Locked |
#1
EXPORTER PROFILE #1 OF 4 — TRADE FLOW MAP
INTAS PHARMACEUTICALS LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P1.3 Netherlands absorbs $160K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 5 importers per destination.
#2
EXPORTER PROFILE #2 OF 4
FRESENIUS KABI ONCOLOGY LTD
New Delhi · India’s #2 cytarabine supplier by USD · 2025-Q4
2025-Q4 USD
$514K
39.6% market share
SHIPMENTS
12
avg $43K/ship
COUNTRIES
6
destination markets
BUYERS
8
6 single-sourced
BRANDED
92%
of shipments
DOSAGE FORMS
2
product types
TOP 6 DESTINATIONS
South Africa is the #1 market at $367K (71% of trade), followed by Germany at $62K. 6 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | South Africa | $367K | 5 | 71.4% |
| 2 | Germany | $62K | 3 | 12.0% |
| 3 | Malaysia | $58K | 1 | 11.2% |
| 4 | Thailand | $25K | 1 | 4.8% |
| 5 | Pakistan | $3K | 1 | 0.5% |
| 6 | Hungary | $546 | 1 | 0.1% |
MONTHLY TREND
Nov peaked at $494K. Oct was the weakest at $0.
PRODUCT MIX
Injection dominates at 66% of trade. Solution (34.3%) and others are secondary formulations.
TOP BUYERS · 6/7 LOCKED IN
6 of 7 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| FRESENIUS KABI SOUTH A… | South Africa | $350K | ⚠ Locked |
| FRESENIUS KABI DEUTSCH… | Germany | $62K | ⚠ Locked |
| FRESENIUS KABI MALAYSI… | Malaysia | $58K | ⚠ Locked |
| FRESENIUS KABI (THAILA… | Thailand | $25K | ⚠ Locked |
| FRESENIUS KABI SOUTH A… | South Africa | $8K | ⚠ Locked |
| Undisclosed buyer | South Africa | $8K | N/A |
| ATCO PHARMA INTERNATIO… | Pakistan | $3K | ⚠ Locked |
| EUROFINS BIOPHARMA PRO… | Hungary | $546 | 2 sup. |
#2
EXPORTER PROFILE #2 OF 4 — TRADE FLOW MAP
FRESENIUS KABI ONCOLOGY LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P2.3 South Africa absorbs $367K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 3 importers per destination.
#3
EXPORTER PROFILE #3 OF 4
UNITED BIOTECH PVT LTD
New Delhi · India’s #3 cytarabine supplier by USD · 2025-Q4
2025-Q4 USD
$40K
3.0% market share
SHIPMENTS
12
avg $3K/ship
COUNTRIES
4
destination markets
BUYERS
5
4 single-sourced
BRANDED
92%
of shipments
DOSAGE FORMS
1
product types
TOP 4 DESTINATIONS
Sri Lanka is the #1 market at $18K (45% of trade), followed by Kazakhstan at $13K. 4 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Sri Lanka | $18K | 1 | 44.9% |
| 2 | Kazakhstan | $13K | 3 | 31.9% |
| 3 | Nepal | $6K | 7 | 15.6% |
| 4 | Cambodia | $3K | 1 | 7.6% |
MONTHLY TREND
Nov peaked at $27K. Oct was the weakest at $0.
PRODUCT MIX
Injection dominates at 100% of trade.
TOP BUYERS · 4/4 LOCKED IN
4 of 4 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| PEOPLES BANK | Sri Lanka | $18K | ⚠ Locked |
| KAZBIOTECH LLP | Kazakhstan | $13K | ⚠ Locked |
| NIKHIL PHARMA PVT LTD | Nepal | $3K | ⚠ Locked |
| SAK CAM PHARMA CO LTD | Cambodia | $3K | ⚠ Locked |
| Undisclosed buyer | Nepal | $3K | N/A |
#3
EXPORTER PROFILE #3 OF 4 — TRADE FLOW MAP
UNITED BIOTECH PVT LTD — Supplier → Country → Importer
4 destination countries, top 5 importers per country
Fig 5.P3.3 Sri Lanka absorbs $18K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 2 importers per destination.
#10
EXPORTER PROFILE #4 OF 4
ZUVIUS LIFESCIENCES PVT LTD
Ghatkopar (E) · India’s #10 cytarabine supplier by USD · 2025-Q4
2025-Q4 USD
$6K
0.5% market share
SHIPMENTS
9
avg $689/ship
COUNTRIES
2
destination markets
BUYERS
4
3 single-sourced
BRANDED
100%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
Myanmar is the #1 market at $5K (86% of trade), followed by Nigeria at $856. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Myanmar | $5K | 3 | 86.2% |
| 2 | Nigeria | $856 | 6 | 13.8% |
MONTHLY TREND
Nov peaked at $6K. Oct was the weakest at $0.
PRODUCT MIX
Injection dominates at 100% of trade.
TOP BUYERS · 3/3 LOCKED IN
3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| THEIKDI MAUG CO LTD | Myanmar | $4K | ⚠ Locked |
| IMPERIAL PHOENIX CO LTD | Myanmar | $2K | ⚠ Locked |
| DOMAKS INVESTMENT LTD | Nigeria | $563 | ⚠ Locked |
| Undisclosed buyer | Nigeria | $293 | N/A |
#10
EXPORTER PROFILE #4 OF 4 — TRADE FLOW MAP
ZUVIUS LIFESCIENCES PVT LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P4.3 Myanmar absorbs $5K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
51 importers across 49 countries — who is buying Indian cytarabine and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 57.0% of total USD. 94% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian cytarabine. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 FRESENIUS KABI SOUTH AFRICA (PTY) is the #1 importer at $350K (26.9%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
94%
Single-source
48 buyers rely on exactly 1 Indian supplier
2%
Dual-source
1 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
4%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source cytarabine from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Netherlands 5 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| BROCACEF NL:LOCAL | INTAS PHARMACEUTICAL… | $47K | $9.521 | Injection |
| BROCACEF NL:EU HUB | INTAS PHARMACEUTICAL… | $37K | $9.312 | Injection |
| BROCACEF NL : LOCAL | INTAS PHARMACEUTICAL… | $142.419 | $0.060 | Injection |
| BROCACEF NL : EU HUB | INTAS PHARMACEUTICAL… | $105.434 | $0.047 | Injection |
| ACCORD HEALTHCARE FRAN… | INTAS PHARMACEUTICAL… | $35.414 | $0.033 | Injection |
Sri Lanka 4 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| PEOPLES BANK | UNITED BIOTECH PVT LTD | $18K | $4.440 | Injection |
| THE ESSES PHARMACY (PR… | GETWELL PHARMA INDIA… | $7K | $6.886 | Injection |
| THE ESSES PHARMACY (PV… | PLEASANT EXPORTS | $1K | $4.970 | Injection |
| AS PER INVOICE SRI LANKA | VAMA LIFECARE PVT LTD | $1.208 | $0.020 | Injection |
South Africa 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| FRESENIUS KABI SOUTH A… | FRESENIUS KABI ONCOL… | $350K | $12.756 | Solution |
| FRESENIUS KABI SOUTH A… | FRESENIUS KABI ONCOL… | $8K | $2.421 | Injection |
Yemen 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ALFWASEL FOR GENERAL T… | GLS PHARMA LTD | $23K | $1.792 | Vial |
| AL-NOOR FOR DRUGS & ME… | J.A. UNITED EXPORTS … | $703.107 | $0.879 | Injection |
Colombia 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| AL PHARMA SAS | NAPROD LIFE SCIENCES… | $12K | $3.594 | Injection |
| ADVANCE SCIENTIFIC DE … | SAKAR HEALTHCARE LTD | $5K | $4.592 | Injection |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | FRESENIUS KABI SOUTH… | South Africa | $350K | $117K | Premium |
| 2 | FRESENIUS KABI DEUTS… | Germany | $62K | $21K | Mid |
| 3 | FRESENIUS KABI MALAY… | Malaysia | $58K | $58K | Premium |
| 4 | BROCACEF NL:LOCAL | Netherlands | $47K | $24K | Mid |
| 5 | BROCACEF NL:EU HUB | Netherlands | $37K | $5K | Budget |
| 6 | FRESENIUS KABI (THAI… | Thailand | $25K | $25K | Mid |
| 7 | ALFWASEL FOR GENERAL… | Yemen | $23K | $8K | Budget |
| 8 | PEOPLES BANK | Sri Lanka | $18K | $18K | Mid |
| 9 | ACCORD HEALTHCARE SI… | Greece | $15K | $8K | Budget |
| 10 | KAZBIOTECH LLP | Kazakhstan | $13K | $4K | Budget |
| 11 | AL PHARMA SAS | Colombia | $12K | $12K | Budget |
| 12 | DITA ESTFARM SRL | Moldova | $9K | $9K | Budget |
| 13 | SEVEN PHARMA GUATEMA… | Guatemala | $9K | $9K | Budget |
| 14 | FRESENIUS KABI SOUTH… | South Africa | $8K | $8K | Budget |
| 15 | RUS MED EXPORTS FZE | Russia | $8K | $8K | Budget |
| 16 | ACCORD UK | United Kingdom | $8K | $4K | Budget |
| 17 | ACCORD HEALTHCARE, SLU | Spain | $8K | $4K | Budget |
| 18 | THE ESSES PHARMACY (… | Sri Lanka | $7K | $3K | Budget |
| 19 | ADVANCE SCIENTIFIC D… | Colombia | $5K | $5K | Budget |
| 20 | ETEMED MOSLEH LTD | Afghanistan | $5K | $1K | Budget |
| 21 | OUBARI-HABBOUSH PHARMA | Lebanon | $4K | $4K | Budget |
| 22 | THEIKDI MAUG CO LTD | Myanmar | $4K | $2K | Budget |
| 23 | NIKHIL PHARMA PVT LTD | Nepal | $3K | $809.000 | Budget |
| 24 | SAK CAM PHARMA CO LTD | Cambodia | $3K | $3K | Budget |
| 25 | ATCO PHARMA INTERNAT… | Pakistan | $3K | $3K | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 INTAS PHARMACEUTICALS LTD → FRESENIUS KABI SOUTH AFRICA (PTY) is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian cytarabine prices vary by supplier, country and dosage form
KEY TAKEAWAY
Cytarabine prices span 1104× ($0.018 → $19.85). The coefficient of variation is 0.91. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.018 | Lowest observed unit price |
| P5 | $0.038 | 5th percentile |
| P25 | $1.29 | 25th percentile (Q1) |
| Median | $4.61 | 50th percentile (Q2) |
| P75 | $6.89 | 75th percentile (Q3) |
| P95 | $17.61 | 95th percentile |
| Max | $19.85 | Highest observed unit price |
| Mean | $5.36 | Arithmetic average |
| CV | 91% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 PLEASANT EXPORTS prices at $7.88/unit vs market median $4.61.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. GLS PHARMA LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. INTAS PHARMACEUTICALS LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. VHB MEDI SCIENCES Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. CELON LABORATORIES PVT Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | KINGS GLOBAL BIO… | United Arab Emirates | Injection | 0 | $26.21 | $74.90 | Sterile formulation premium |
| Nov 2025 | ZIL PHARMA | United Arab Emirates | Injection | 500 | $13K | $25.61 | Sterile formulation premium |
| Oct 2025 | INTAS PHARMACEUT… | Greece | Injection | 61 | $1K | $19.85 | Sterile formulation premium |
| Oct 2025 | INTAS PHARMACEUT… | Greece | Injection | 927 | $18K | $19.85 | Sterile formulation premium |
| Nov 2025 | INTAS PHARMACEUT… | Austria | Injection | 928 | $18K | $19.22 | Sterile formulation premium |
| Nov 2025 | INTAS PHARMACEUT… | Austria | Injection | 61 | $1K | $19.22 | Sterile formulation premium |
| Oct 2025 | INTAS PHARMACEUT… | France | Injection | 61 | $1K | $18.98 | Sterile formulation premium |
| Oct 2025 | INTAS PHARMACEUT… | France | Injection | 4K | $69K | $18.98 | Sterile formulation premium |
| Nov 2025 | INTAS PHARMACEUT… | Netherlands | Injection | 61 | $1K | $18.78 | Sterile formulation premium |
| Nov 2025 | INTAS PHARMACEUT… | Netherlands | Injection | 61 | $1K | $18.78 | Sterile formulation premium |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | BIOZENTA LIFESCI… | Egypt | Injection | 350 | $1.83 | $0.0052 | Sterile formulation premium |
| Dec 2025 | UNITED BIOTECH P… | Kazakhstan | Injection | 5K | $52.73 | $0.011 | Sterile formulation premium |
| Dec 2025 | VAMA LIFECARE PV… | Sri Lanka | Injection | 50 | $0.899 | $0.018 | Sterile formulation premium |
| Dec 2025 | AMARI TRADE ALLI… | Turkey | Injection | 200 | $4.09 | $0.020 | Sterile formulation premium |
| Dec 2025 | BIOZENTA LIFESCI… | Egypt | Injection | 700 | $14.43 | $0.021 | Sterile formulation premium |
| Dec 2025 | DISTINCT IMPEX P… | Jamaica | Injection | 10 | $0.239 | $0.024 | Sterile formulation premium |
| Dec 2025 | M T MADON EXPORTS | Somalia | Injection | 100 | $2.75 | $0.028 | Sterile formulation premium |
| Dec 2025 | AMARI TRADE ALLI… | Turkey | Injection | 400 | $11.20 | $0.028 | Sterile formulation premium |
| Dec 2025 | VAMA HEALTH WORL… | Ghana | Injection | 50 | $1.42 | $0.028 | Sterile formulation premium |
| Dec 2025 | VAMA LIFECARE PV… | Sri Lanka | Injection | 10 | $0.308 | $0.031 | Sterile formulation premium |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship cytarabine, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Cytarabine leaves India through 11+ ports. The top 5 (DELHI AIR, MUNDRA SEA, AHMEDABAD AIR) handle 96.0% of total USD. AIR moves 66% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 DELHI AIR handles $501K — top 11 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 JOHANNESBURG - JOHAN is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 66% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$775K
59.7% of USD · 66.1% of ships
SEA
$459K
35.3% of USD · 32.2% of ships
ICD
$65K
5.0% of USD · 1.7% of ships
Fig 8.3 The dominant corridor is MUNDRA SEA → Sea → Europe ($413K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Netherlands is the most concentrated destination (HHI 10000, 1 suppliers). Kenya is the most competitive (HHI 5098).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Netherlands (HHI 10,000) is the most concentrated — Kenya (HHI 5,098) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| FRESENIUS KABI SOUTH… | South Africa | FRESENIUS KABI O… | $350K | 3 | HIGH |
| FRESENIUS KABI DEUTS… | Germany | FRESENIUS KABI O… | $62K | 3 | MEDIUM |
| FRESENIUS KABI MALAY… | Malaysia | FRESENIUS KABI O… | $58K | 1 | MEDIUM |
| BROCACEF NL:LOCAL | Netherlands | INTAS PHARMACEUT… | $47K | 2 | MEDIUM |
| BROCACEF NL:EU HUB | Netherlands | INTAS PHARMACEUT… | $37K | 8 | MEDIUM |
| FRESENIUS KABI (THAI… | Thailand | FRESENIUS KABI O… | $25K | 1 | MEDIUM |
| ALFWASEL FOR GENERAL… | Yemen | GLS PHARMA LTD | $23K | 3 | MEDIUM |
| PEOPLES BANK | Sri Lanka | UNITED BIOTECH P… | $18K | 1 | MEDIUM |
Conclusion: 48 buyers depend on exactly one Indian supplier, representing $751K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| South Africa | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Netherlands | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| United Kingdom | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Poland | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| France | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Germany | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Malaysia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Austria | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Greece | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Brazil | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Sri Lanka | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Thailand | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Yemen | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Colombia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| United Arab Emirates | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 15 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in South Africa | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Netherlands lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter South Africa (1 suppliers) | This Q | HIGH |
| A6 | Enter Kazakhstan (2 suppliers) | This Q | MED |
| A8 | Build Netherlands distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for South Africa tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | South Africa | Africa | 1 | $367K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Kazakhstan | Asia | 2 | $13K | +2011.8% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Netherlands | Other | 1 | $160K | -91.6% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | United Kingdom | Other | 1 | $148K | -63.5% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Poland | Other | 1 | $88K | -99.4% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | France | Other | 1 | $79K | -87.1% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Germany | Other | 1 | $62K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Malaysia | Asia | 1 | $58K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Austria | Other | 1 | $52K | -11% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Greece | Other | 1 | $48K | -49.7% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Brazil | Other | 1 | $41K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Sri Lanka | Asia | 4 | $26K | 0% | LOW | Low competition (4 suppliers), accessible market |
| 13 | Thailand | Asia | 1 | $25K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Yemen | Other | 2 | $24K | -98.8% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Colombia | Other | 2 | $17K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 239 2025-Q4 Cytarabine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/cytarabine
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 239 2025-Q4 cytarabine shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian cytarabine shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
239
across all regions
TOTAL USD
$1.30M
2025-Q4 FOB value
UNITS
228.8K
tablets, capsules, etc.
SUPPLIERS
42
Indian exporters
BUYERS
51
global importers
COUNTRIES
49
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $376K (29.0%), spanning 14 countries.
42 Indian suppliers shipped to 51 buyers across 49 countries — average shipment value $5K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
14 countries · 35 shipments · $376K · 18 Indian suppliers · 12 buyers
SHIPMENTS
35
USD
$376K
COUNTRIES
14
SUPPLIERS
18
BUYERS
12
HHI
9,496
concentrated
Top 14 destination countries in Africa
1
South Africa (97.4%)
$367K
2
Tanzania (0.7%)
$3K
3
Rwanda (0.5%)
$2K
4
Malawi (0.4%)
$1K
5
Ghana (0.4%)
$1K
6
Nigeria (0.2%)
$856.17
7
Kenya (0.1%)
$514.54
8
Burkina Faso (0.1%)
$447.75
9
Burundi (0.1%)
$285.00
10
Ethiopia (0.0%)
$159.25
11
Seychelles (0.0%)
$143.17
12
Cote d'Ivoire (0.0%)
$74.25
13
Egypt (0.0%)
$16.26
14
Somalia (0.0%)
$2.75
Top 18 Indian suppliers into Africa
1
FRESENIUS KABI ONCOLOGY LTD
$367K
2
AASHVI PHARMACEUTICALS PVT LTD
$3K
3
PNT PHARMA
$2K
4
MATHI ASSOCIATES
$1K
5
WELLKIND PHARMACEUTICAL PVT LTD
$1K
6
ZUVIUS LIFESCIENCES PVT LTD
$856.17
7
SANSKRUTI PHARMA
$447.75
8
R.S. SURGIPHARM PVT LTD
$347.44
9
BRUCK PHARMA PVT LTD
$285.00
10
MATOSHREE HEALTH CARE PVT LTD
$159.25
11
SAYAR LIFE-CARE
$143.17
12
RMPL PHARMA LLP
$95.41
13
DM WORLDWIDE TRADING
$74.25
14
AMARI TRADE ALLIANCE LLP
$71.69
15
BARAKAH BIOHEALTH LLP
$63.91
16
BIOZENTA LIFESCIENCE PVT LTD
$16.26
17
M T MADON EXPORTS
$2.75
18
VAMA HEALTH WORLD LLP
$1.42
Top 10 Africa importers
1
FRESENIUS KABI SOUTH AFRICA (PTY) · South Africa
$350K
2
FRESENIUS KABI SOUTH AFRICA (PTY) L · South Africa
$8K
3
TO THE · Rwanda
$2K
4
PHARMACHEIME LTD · Malawi
$1K
5
NEW AFRICA SOFTWARE SOLUTION LTD · Ghana
$1K
6
DOMAKS INVESTMENT LTD · Nigeria
$562.79
7
MINISTRY OF HEALTH ( CLAUDE JULIEN · Seychelles
$143.17
8
ABU AHMED · Kenya
$71.69
9
MOHAMED AHEMED MOHAMUD · Somalia
$2.75
10
AS PER INVOICE GHANA · Ghana
$1.42
Top 4 dosage forms
1
Injection
$198K
2
Solution
$176K
3
product
$2K
4
Vial
$143.17
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $63.91 | $63.91 |
| Nov | 23 | $374K | $16K |
| Dec | 11 | $3K | $239.86 |
Shipment register · 35 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — FRESENIUS KABI ONCOLOGY LTD · 5 shipments · $367K | |||||||||||
| 1 | Nov 2025 | FRESENIUS KABI SOUTH AFRICA (PTY) | South Africa | Solution | 13.7K | VLS | $12.84 | $176K | DELHI AIR | JOHANNESBURG - JOHAN | AIR |
| 2 | Nov 2025 | FRESENIUS KABI SOUTH AFRICA (PTY) | South Africa | Injection | 8.9K | NOS | $12.67 | $113K | DELHI AIR | JOHANNESBURG - JOHAN | AIR |
| 3 | Nov 2025 | FRESENIUS KABI SOUTH AFRICA (PTY) | South Africa | Injection | 4.8K | NOS | $12.67 | $61K | DELHI AIR | JOHANNESBURG - JOHAN | AIR |
| 4 | Nov 2025 | FRESENIUS KABI SOUTH AFRICA (PTY) L | South Africa | Injection | 3.5K | NOS | $2.42 | $8K | DELHI AIR | JOHANNESBURG - JOHAN | AIR |
| 5 | Nov 2025 | UNKNOWN BUYER | South Africa | Injection | 3.5K | NOS | $2.42 | $8K | DELHI AIR | JOHANNESBURG - JOHAN | AIR |
| SUPPLIER #2 — AASHVI PHARMACEUTICALS PVT LTD · 1 shipments · $3K | |||||||||||
| 6 | Nov 2025 | UNLISTED BUYER | Tanzania | Injection | 2.0K | NOS | $1.30 | $3K | MUMBAI AIR (SAHAR) | DAR ES SALAM (DARESS | AIR |
| SUPPLIER #3 — PNT PHARMA · 1 shipments · $2K | |||||||||||
| 7 | Dec 2025 | TO THE | Rwanda | product | 2.0K | NOS | $0.876 | $2K | MUMBAI AIR (SAHAR) | KIGALI - | AIR |
| SUPPLIER #4 — MATHI ASSOCIATES · 2 shipments · $1K | |||||||||||
| 8 | Nov 2025 | PHARMACHEIME LTD | Malawi | Injection | 200 | VLS | $1.02 | $203.04 | MUMBAI AIR (SAHAR) | LILONGWE | AIR |
| 9 | Nov 2025 | PHARMACHEIME LTD | Malawi | Injection | 350 | VLS | $3.38 | $1K | MUMBAI AIR (SAHAR) | LILONGWE | AIR |
| SUPPLIER #5 — WELLKIND PHARMACEUTICAL PVT LTD · 1 shipments · $1K | |||||||||||
| 10 | Nov 2025 | NEW AFRICA SOFTWARE SOLUTION LTD | Ghana | Injection | 500 | NOS | $2.64 | $1K | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #6 — ZUVIUS LIFESCIENCES PVT LTD · 6 shipments · $856.17 | |||||||||||
| 11 | Nov 2025 | DOMAKS INVESTMENT LTD | Nigeria | Injection | 160 | NOS | $0.978 | $156.47 | DELHI AIR | LAGOS | AIR |
| 12 | Nov 2025 | DOMAKS INVESTMENT LTD | Nigeria | Injection | 140 | NOS | $0.978 | $136.91 | DELHI AIR | LAGOS | AIR |
| 13 | Nov 2025 | UNKNOWN BUYER | Nigeria | Injection | 160 | NOS | $0.978 | $156.47 | DELHI AIR | LAGOS | AIR |
| 14 | Nov 2025 | UNKNOWN BUYER | Nigeria | Injection | 140 | NOS | $0.978 | $136.91 | DELHI AIR | LAGOS | AIR |
| 15 | Nov 2025 | DOMAKS INVESTMENT LTD | Nigeria | Injection | 160 | NOS | $0.898 | $143.69 | DELHI AIR | LAGOS | AIR |
| 16 | Nov 2025 | DOMAKS INVESTMENT LTD | Nigeria | Injection | 140 | NOS | $0.898 | $125.73 | DELHI AIR | LAGOS | AIR |
| SUPPLIER #7 — SANSKRUTI PHARMA · 6 shipments · $447.75 | |||||||||||
| 17 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 30 | VLS | $1.19 | $35.63 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 18 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 40 | VLS | $3.86 | $154.38 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 19 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 30 | VLS | $1.14 | $34.25 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 20 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 40 | VLS | $3.71 | $148.44 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 21 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 20 | VLS | $3.71 | $74.21 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 22 | Dec 2025 | UNLISTED BUYER | Burkina Faso | Injection | 20 | VLS | $0.042 | $0.836 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| SUPPLIER #8 — R.S. SURGIPHARM PVT LTD · 2 shipments · $347.44 | |||||||||||
| 23 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 100 | VLS | $0.539 | $53.92 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 24 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 100 | VLS | $2.94 | $293.52 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #9 — BRUCK PHARMA PVT LTD · 1 shipments · $285.00 | |||||||||||
| 25 | Dec 2025 | UNLISTED BUYER | Burundi | Injection | 300 | NOS | $0.950 | $285.00 | MUMBAI AIR (SAHAR) | BUJUMBURA | AIR |
| SUPPLIER #10 — MATOSHREE HEALTH CARE PVT LTD · 1 shipments · $159.25 | |||||||||||
| 26 | Dec 2025 | UNKNOWN BUYER | Ethiopia | Injection | 200 | NOS | $0.796 | $159.25 | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| SUPPLIER #11 — SAYAR LIFE-CARE · 1 shipments · $143.17 | |||||||||||
| 27 | Nov 2025 | MINISTRY OF HEALTH ( CLAUDE JULIEN | Seychelles | Vial | 24 | NOS | $5.97 | $143.17 | CHENNAI AIR | MAHE ISLAND | AIR |
| SUPPLIER #12 — RMPL PHARMA LLP · 1 shipments · $95.41 | |||||||||||
| 28 | Nov 2025 | UNLISTED BUYER | Kenya | Injection | 50 | NOS | $1.91 | $95.41 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #13 — DM WORLDWIDE TRADING · 1 shipments · $74.25 | |||||||||||
| 29 | Dec 2025 | UNLISTED BUYER | Cote d'Ivoire | Injection | 10 | NOS | $7.42 | $74.25 | AHMEDABAD AIR | ABIDJAN | AIR |
| SUPPLIER #14 — AMARI TRADE ALLIANCE LLP · 1 shipments · $71.69 | |||||||||||
| 30 | Nov 2025 | ABU AHMED | Kenya | Injection | 25 | VLS | $2.87 | $71.69 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #15 — BARAKAH BIOHEALTH LLP · 1 shipments · $63.91 | |||||||||||
| 31 | Oct 2025 | UNLISTED BUYER | Tanzania | Injection | 50 | NOS | $1.28 | $63.91 | CHENNAI AIR | DAR ES SALAM (DARESS | AIR |
| SUPPLIER #16 — BIOZENTA LIFESCIENCE PVT LTD · 2 shipments · $16.26 | |||||||||||
| 32 | Dec 2025 | UNLISTED BUYER | Egypt | Injection | 700 | VLS | $0.021 | $14.43 | DELHI AIR | CAIRO | AIR |
| 33 | Dec 2025 | UNLISTED BUYER | Egypt | Injection | 350 | VLS | $0.0052 | $1.83 | DELHI AIR | CAIRO | AIR |
| SUPPLIER #17 — M T MADON EXPORTS · 1 shipments · $2.75 | |||||||||||
| 34 | Dec 2025 | MOHAMED AHEMED MOHAMUD | Somalia | Injection | 100 | NOS | $0.028 | $2.75 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| SUPPLIER #18 — VAMA HEALTH WORLD LLP · 1 shipments · $1.42 | |||||||||||
| 35 | Dec 2025 | AS PER INVOICE GHANA | Ghana | Injection | 50 | NOS | $0.028 | $1.42 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
16 countries · 64 shipments · $191K · 23 Indian suppliers · 23 buyers
SHIPMENTS
64
USD
$191K
COUNTRIES
16
SUPPLIERS
23
BUYERS
23
HHI
2,634
concentrated
Top 16 destination countries in Asia
1
Malaysia (30.1%)
$58K
2
Sri Lanka (13.5%)
$26K
3
Thailand (13.0%)
$25K
4
Yemen (12.5%)
$24K
5
United Arab Emirates (7.4%)
$14K
6
Kazakhstan (6.9%)
$13K
7
Myanmar (3.2%)
$6K
8
Nepal (3.2%)
$6K
9
Afghanistan (2.5%)
$5K
10
Singapore (2.3%)
$4K
11
Lebanon (2.3%)
$4K
12
Cambodia (1.6%)
$3K
13
Pakistan (1.4%)
$3K
14
China (0.1%)
$97.09
15
Turkey (0.0%)
$15.30
16
Indonesia (0.0%)
$3.74
Top 23 Indian suppliers into Asia
1
FRESENIUS KABI ONCOLOGY LTD
$85K
2
UNITED BIOTECH PVT LTD
$40K
3
GLS PHARMA LTD
$23K
4
ZIL PHARMA
$13K
5
GETWELL PHARMA INDIA PVT LTD
$7K
6
ZUVIUS LIFESCIENCES PVT LTD
$5K
7
RESCUERS LIFE SCIENCES LTD
$5K
8
VHB MEDI SCIENCES LTD
$4K
9
HEET HEALTHCARE PVT LTD
$3K
10
PLEASANT EXPORTS
$1K
11
DROPS PHARMA PVT LTD
$1K
12
LEOWIN HEALTHCARE LLP
$1K
13
RMPL PHARMA LLP
$1K
14
BRUCK PHARMA PVT LTD
$821.98
15
J.A. UNITED EXPORTS PVT LTD
$703.11
16
MEDWISE OVERSEAS PVT LTD
$596.55
17
JMB PHARMACEUTICALS PVT LTD
$97.09
18
KINGS GLOBAL BIOTECH LTD
$26.21
19
AMARI TRADE ALLIANCE LLP
$15.30
20
AANYA GLOBAL
$14.12
21
GENEX PHARMA
$3.74
22
VAMA LIFECARE PVT LTD
$1.21
23
MCARE IMPEX PVT LTD
$0.0000
Top 21 Asia importers
1
FRESENIUS KABI MALAYSIA SDN BHD · Malaysia
$58K
2
FRESENIUS KABI (THAILAND) LTD · Thailand
$25K
3
ALFWASEL FOR GENERAL TRADING · Yemen
$23K
4
PEOPLES BANK · Sri Lanka
$18K
5
KAZBIOTECH LLP · Kazakhstan
$13K
6
THE ESSES PHARMACY (PRIVATE)LTD · Sri Lanka
$7K
7
ETEMED MOSLEH LTD · Afghanistan
$5K
8
OUBARI-HABBOUSH PHARMA · Lebanon
$4K
9
THEIKDI MAUG CO LTD · Myanmar
$4K
10
NIKHIL PHARMA PVT LTD · Nepal
$3K
11
SAK CAM PHARMA CO LTD · Cambodia
$3K
12
ATCO PHARMA INTERNATIONAL PVT LTD · Pakistan
$3K
13
IMPERIAL PHOENIX CO LTD · Myanmar
$2K
14
THE ESSES PHARMACY (PVT) LTD · Sri Lanka
$1K
15
AL-NOOR FOR DRUGS & MEDICAL APPLIAN · Yemen
$703.11
16
MEDIMART DRUG STORE · United Arab Emirates
$342.79
17
DALIAN CHAOHONGSUPPLY CHAIN MANAGEM · China
$97.09
18
TO THE IMPORT MANAGER · United Arab Emirates
$26.21
19
ABU ABDU · Turkey
$15.30
20
AS PER INVOICE SRI LANKA · Sri Lanka
$1.21
21
BAWABAT ALDAWA MEDICINEES STORE LLC · United Arab Emirates
$0.0000
Top 2 dosage forms
1
Injection
$168K
2
Vial
$23K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 10 | $25K | $3K |
| Nov | 29 | $138K | $5K |
| Dec | 25 | $28K | $1K |
Shipment register · 64 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — FRESENIUS KABI ONCOLOGY LTD · 3 shipments · $85K | |||||||||||
| 1 | Nov 2025 | FRESENIUS KABI (THAILAND) LTD | Thailand | Injection | 3.1K | VLS | $7.99 | $25K | DELHI AIR | BANGKOK | AIR |
| 2 | Nov 2025 | FRESENIUS KABI MALAYSIA SDN BHD | Malaysia | Injection | 7.2K | VLS | $7.99 | $58K | DELHI AIR | KUALA LUMPUR - INT'L | AIR |
| 3 | Dec 2025 | ATCO PHARMA INTERNATIONAL PVT LTD | Pakistan | Injection | 1.8K | NOS | $1.51 | $3K | DELHI AIR | KARACHI - | AIR |
| SUPPLIER #2 — UNITED BIOTECH PVT LTD · 12 shipments · $40K | |||||||||||
| 4 | Nov 2025 | NIKHIL PHARMA PVT LTD | Nepal | Injection | 300 | PCS | $0.933 | $279.92 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 5 | Nov 2025 | NIKHIL PHARMA PVT LTD | Nepal | Injection | 300 | PCS | $5.75 | $2K | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 6 | Nov 2025 | NIKHIL PHARMA PVT LTD | Nepal | Injection | 300 | PCS | $3.07 | $922.37 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 7 | Nov 2025 | UNKNOWN BUYER | Nepal | Injection | 300 | PCS | $0.933 | $279.92 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 8 | Nov 2025 | UNKNOWN BUYER | Nepal | Injection | 300 | PCS | $5.75 | $2K | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 9 | Nov 2025 | UNKNOWN BUYER | Nepal | Injection | 300 | PCS | $3.07 | $922.37 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 10 | Nov 2025 | SAK CAM PHARMA CO LTD | Cambodia | Injection | 1.0K | VLS | $2.99 | $3K | TUGHLAKABAD ICD | Sihanoukville (Kompo | ICD |
| 11 | Nov 2025 | PEOPLES BANK | Sri Lanka | Injection | 4.0K | VLS | $4.44 | $18K | DELHI AIR | COLOMBO | AIR |
| 12 | Dec 2025 | NIKHIL PHARMA PVT LTD | Nepal | Injection | 100 | NOS | $3.08 | $308.25 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 13 | Dec 2025 | KAZBIOTECH LLP | Kazakhstan | Injection | 4.6K | NOS | $0.0000 | $0.0000 | DELHI AIR | ALMATY | SEA |
| 14 | Dec 2025 | KAZBIOTECH LLP | Kazakhstan | Injection | 4.6K | NOS | $0.011 | $52.73 | DELHI AIR | ALMATY | SEA |
| 15 | Dec 2025 | KAZBIOTECH LLP | Kazakhstan | Injection | 3.0K | NOS | $4.18 | $13K | DELHI AIR | ALMATY | AIR |
| SUPPLIER #3 — GLS PHARMA LTD · 3 shipments · $23K | |||||||||||
| 16 | Oct 2025 | ALFWASEL FOR GENERAL TRADING | Yemen | Vial | 3.0K | NOS | $0.488 | $1K | HYDERABAD AIR | AMMAN | AIR |
| 17 | Oct 2025 | ALFWASEL FOR GENERAL TRADING | Yemen | Vial | 7.0K | NOS | $1.65 | $12K | HYDERABAD AIR | AMMAN | AIR |
| 18 | Oct 2025 | ALFWASEL FOR GENERAL TRADING | Yemen | Vial | 3.0K | NOS | $3.42 | $10K | HYDERABAD AIR | AMMAN | AIR |
| SUPPLIER #4 — ZIL PHARMA · 1 shipments · $13K | |||||||||||
| 19 | Nov 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 500 | NOS | $25.61 | $13K | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #5 — GETWELL PHARMA INDIA PVT LTD · 2 shipments · $7K | |||||||||||
| 20 | Dec 2025 | THE ESSES PHARMACY (PRIVATE)LTD | Sri Lanka | Injection | 900 | NOS | $6.89 | $6K | DELHI AIR | COLOMBO | AIR |
| 21 | Dec 2025 | THE ESSES PHARMACY (PRIVATE)LTD | Sri Lanka | Injection | 100 | NOS | $6.89 | $688.64 | DELHI AIR | COLOMBO | AIR |
| SUPPLIER #6 — ZUVIUS LIFESCIENCES PVT LTD · 3 shipments · $5K | |||||||||||
| 22 | Nov 2025 | IMPERIAL PHOENIX CO LTD | Myanmar | Injection | 1.0K | NOS | $1.77 | $2K | NHAVA SHEVA SEA (JNPT) | Yangon | SEA |
| 23 | Nov 2025 | THEIKDI MAUG CO LTD | Myanmar | Injection | 1.0K | NOS | $1.79 | $2K | NHAVA SHEVA SEA (JNPT) | Yangon | SEA |
| 24 | Nov 2025 | THEIKDI MAUG CO LTD | Myanmar | Injection | 1.0K | NOS | $1.79 | $2K | NHAVA SHEVA SEA (JNPT) | Yangon | SEA |
| SUPPLIER #7 — RESCUERS LIFE SCIENCES LTD · 4 shipments · $5K | |||||||||||
| 25 | Dec 2025 | ETEMED MOSLEH LTD | Afghanistan | Injection | 1.0K | NOS | $1.84 | $2K | DELHI AIR | KABUL | AIR |
| 26 | Dec 2025 | ETEMED MOSLEH LTD | Afghanistan | Injection | 1.5K | NOS | $0.347 | $520.45 | DELHI AIR | KABUL | AIR |
| 27 | Dec 2025 | ETEMED MOSLEH LTD | Afghanistan | Injection | 1.0K | NOS | $1.84 | $2K | DELHI AIR | KABUL | AIR |
| 28 | Dec 2025 | ETEMED MOSLEH LTD | Afghanistan | Injection | 1.5K | NOS | $0.347 | $520.45 | DELHI AIR | KABUL | AIR |
| SUPPLIER #8 — VHB MEDI SCIENCES LTD · 1 shipments · $4K | |||||||||||
| 29 | Nov 2025 | OUBARI-HABBOUSH PHARMA | Lebanon | Injection | 1.8K | VLS | $2.00 | $4K | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| SUPPLIER #9 — HEET HEALTHCARE PVT LTD · 6 shipments · $3K | |||||||||||
| 30 | Nov 2025 | UNLISTED BUYER | Singapore | Injection | 500 | NOS | $0.898 | $449.23 | AHMEDABAD AIR | SINGAPORE | AIR |
| 31 | Nov 2025 | UNLISTED BUYER | Singapore | Injection | 12 | NOS | $2.50 | $29.95 | AHMEDABAD AIR | SINGAPORE | AIR |
| 32 | Nov 2025 | UNLISTED BUYER | Singapore | Injection | 480 | NOS | $2.50 | $1K | AHMEDABAD AIR | SINGAPORE | AIR |
| 33 | Nov 2025 | UNKNOWN BUYER | Singapore | Injection | 500 | NOS | $0.898 | $449.23 | AHMEDABAD AIR | SINGAPORE | AIR |
| 34 | Nov 2025 | UNKNOWN BUYER | Singapore | Injection | 12 | NOS | $2.50 | $29.95 | AHMEDABAD AIR | SINGAPORE | AIR |
| 35 | Nov 2025 | UNKNOWN BUYER | Singapore | Injection | 480 | NOS | $2.50 | $1K | AHMEDABAD AIR | SINGAPORE | AIR |
| SUPPLIER #10 — PLEASANT EXPORTS · 2 shipments · $1K | |||||||||||
| 36 | Nov 2025 | THE ESSES PHARMACY (PVT) LTD | Sri Lanka | Injection | 200 | NOS | $3.03 | $606.54 | CHENNAI AIR | COLOMBO | AIR |
| 37 | Nov 2025 | THE ESSES PHARMACY (PVT) LTD | Sri Lanka | Injection | 50 | NOS | $12.72 | $635.89 | CHENNAI AIR | COLOMBO | AIR |
| SUPPLIER #11 — DROPS PHARMA PVT LTD · 4 shipments · $1K | |||||||||||
| 38 | Oct 2025 | MEDIMART DRUG STORE | United Arab Emirates | Injection | 100 | NOS | $3.43 | $342.79 | COCHIN SEA | DUBAI | AIR |
| 39 | Nov 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 100 | NOS | $0.741 | $74.11 | COCHIN AIR | DUBAI | AIR |
| 40 | Nov 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 200 | NOS | $3.16 | $632.41 | COCHIN AIR | DUBAI | AIR |
| 41 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 20 | NOS | $1.36 | $27.28 | COCHIN AIR | DUBAI | AIR |
| SUPPLIER #12 — LEOWIN HEALTHCARE LLP · 4 shipments · $1K | |||||||||||
| 42 | Oct 2025 | UNLISTED BUYER | Singapore | Injection | 20 | NOS | $14.37 | $287.36 | AHMEDABAD AIR | SINGAPORE | AIR |
| 43 | Oct 2025 | UNLISTED BUYER | Singapore | Injection | 100 | NOS | $0.991 | $99.09 | AHMEDABAD AIR | SINGAPORE | AIR |
| 44 | Oct 2025 | UNLISTED BUYER | Singapore | Injection | 200 | NOS | $2.18 | $435.99 | AHMEDABAD AIR | SINGAPORE | AIR |
| 45 | Oct 2025 | UNLISTED BUYER | Singapore | Injection | 110 | NOS | $2.18 | $239.79 | AHMEDABAD AIR | SINGAPORE | AIR |
| SUPPLIER #13 — RMPL PHARMA LLP · 3 shipments · $1K | |||||||||||
| 46 | Nov 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 40 | NOS | $2.73 | $109.08 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 47 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Injection | 40 | NOS | $2.73 | $109.08 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 48 | Dec 2025 | UNLISTED BUYER | Lebanon | Injection | 400 | NOS | $2.01 | $805.28 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| SUPPLIER #14 — BRUCK PHARMA PVT LTD · 1 shipments · $821.98 | |||||||||||
| 49 | Nov 2025 | UNLISTED BUYER | Myanmar | Injection | 500 | NOS | $1.64 | $821.98 | MUMBAI AIR (SAHAR) | YANGON | AIR |
| SUPPLIER #15 — J.A. UNITED EXPORTS PVT LTD · 2 shipments · $703.11 | |||||||||||
| 50 | Nov 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | Injection | 700 | NOS | $0.604 | $422.63 | MUMBAI AIR (SAHAR) | ADEN | AIR |
| 51 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | Injection | 100 | NOS | $2.80 | $280.48 | MUMBAI AIR (SAHAR) | ADEN | AIR |
| SUPPLIER #16 — MEDWISE OVERSEAS PVT LTD · 1 shipments · $596.55 | |||||||||||
| 52 | Oct 2025 | UNKNOWN BUYER | Kazakhstan | Injection | 286 | NOS | $2.09 | $596.55 | AHMEDABAD AIR | ALMATY | AIR |
| SUPPLIER #17 — JMB PHARMACEUTICALS PVT LTD · 3 shipments · $97.09 | |||||||||||
| 53 | Oct 2025 | DALIAN CHAOHONGSUPPLY CHAIN MANAGEM | China | Injection | 100 | NOS | $0.971 | $97.09 | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| 54 | Dec 2025 | UNLISTED BUYER | China | Injection | 300 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| 55 | Dec 2025 | UNLISTED BUYER | China | Injection | 300 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Dalian | AIR |
| SUPPLIER #18 — KINGS GLOBAL BIOTECH LTD · 1 shipments · $26.21 | |||||||||||
| 56 | Dec 2025 | TO THE IMPORT MANAGER | United Arab Emirates | Injection | 0 | KGS | $74.90 | $26.21 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #19 — AMARI TRADE ALLIANCE LLP · 2 shipments · $15.30 | |||||||||||
| 57 | Dec 2025 | ABU ABDU | Turkey | Injection | 200 | NOS | $0.020 | $4.09 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| 58 | Dec 2025 | ABU ABDU | Turkey | Injection | 400 | NOS | $0.028 | $11.20 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| SUPPLIER #20 — AANYA GLOBAL · 2 shipments · $14.12 | |||||||||||
| 59 | Dec 2025 | UNLISTED BUYER | Cambodia | Injection | 18 | PCS | $0.642 | $11.55 | MUMBAI AIR (SAHAR) | PHNOM PENH - POCHENT | AIR |
| 60 | Dec 2025 | UNLISTED BUYER | Cambodia | Vial | 4 | PCS | $0.643 | $2.57 | MUMBAI AIR (SAHAR) | PHNOM PENH - POCHENT | AIR |
| SUPPLIER #21 — GENEX PHARMA · 1 shipments · $3.74 | |||||||||||
| 61 | Dec 2025 | UNLISTED BUYER | Indonesia | Injection | 5 | NOS | $0.747 | $3.74 | MUMBAI AIR (SAHAR) | JAKARTA | AIR |
| SUPPLIER #22 — VAMA LIFECARE PVT LTD · 2 shipments · $1.21 | |||||||||||
| 62 | Dec 2025 | AS PER INVOICE SRI LANKA | Sri Lanka | Injection | 50 | NOS | $0.018 | $0.899 | MUMBAI AIR (SAHAR) | COLOMBO | AIR |
| 63 | Dec 2025 | AS PER INVOICE SRI LANKA | Sri Lanka | Injection | 10 | NOS | $0.031 | $0.308 | MUMBAI AIR (SAHAR) | COLOMBO | AIR |
| SUPPLIER #23 — MCARE IMPEX PVT LTD · 1 shipments · $0.0000 | |||||||||||
| 64 | Dec 2025 | BAWABAT ALDAWA MEDICINEES STORE LLC | United Arab Emirates | Injection | 20 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Jebel Ali | SEA |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
13 countries · 132 shipments · $665K · 5 Indian suppliers · 15 buyers
SHIPMENTS
132
USD
$665K
COUNTRIES
13
SUPPLIERS
5
BUYERS
15
HHI
7,814
concentrated
Top 13 destination countries in Europe
1
Netherlands (24.1%)
$160K
2
United Kingdom (22.2%)
$148K
3
Poland (13.3%)
$88K
4
France (11.9%)
$79K
5
Germany (9.3%)
$62K
6
Austria (7.8%)
$52K
7
Greece (7.2%)
$48K
8
Moldova (1.4%)
$9K
9
Russia (1.3%)
$8K
10
Spain (1.1%)
$8K
11
Malta (0.3%)
$2K
12
Bosnia and Herzegovina (0.2%)
$1K
13
Hungary (0.1%)
$709.79
Top 5 Indian suppliers into Europe
1
INTAS PHARMACEUTICALS LTD
$584K
2
FRESENIUS KABI ONCOLOGY LTD
$62K
3
NAPROD LIFE SCIENCES PVT LTD
$9K
4
RUS MED EXPORTS PVT LTD
$8K
5
BRUCK PHARMA PVT LTD
$1K
Top 13 Europe importers
1
FRESENIUS KABI DEUTSCHLAND GMBH · Germany
$62K
2
BROCACEF NL:LOCAL · Netherlands
$47K
3
BROCACEF NL:EU HUB · Netherlands
$37K
4
ACCORD HEALTHCARE SINGLE MEMBER SA · Greece
$15K
5
DITA ESTFARM SRL · Moldova
$9K
6
RUS MED EXPORTS FZE · Russia
$8K
7
ACCORD UK · United Kingdom
$8K
8
ACCORD HEALTHCARE, SLU · Spain
$8K
9
EUROFINS BIOPHARMA PRODUCT TESTING · Hungary
$659.05
10
BROCACEF NL : LOCAL · Netherlands
$142.42
11
BROCACEF NL : EU HUB · Netherlands
$105.43
12
EUROFINS BIOPHARMA PRODUCT TESTIN · Hungary
$50.74
13
ACCORD HEALTHCARE FRANCE SAS · Netherlands
$35.41
Top 4 dosage forms
1
Injection
$632K
2
Solution
$22K
3
Tablet
$8K
4
Unknown
$3K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 71 | $385K | $5K |
| Nov | 26 | $167K | $6K |
| Dec | 35 | $113K | $3K |
Shipment register · 132 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — INTAS PHARMACEUTICALS LTD · 125 shipments · $584K | |||||||||||
| 1 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 115 | VLS | $7.85 | $902.25 | MUNDRA SEA | ROTTERDAM | SEA |
| 2 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 1.4K | VLS | $6.18 | $9K | MUNDRA SEA | ROTTERDAM | SEA |
| 3 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 904 | VLS | $6.21 | $6K | MUNDRA SEA | ROTTERDAM | SEA |
| 4 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 77 | VLS | $6.21 | $477.80 | MUNDRA SEA | ROTTERDAM | SEA |
| 5 | Oct 2025 | UNLISTED BUYER | United Kingdom | Injection | 85 | VLS | $9.55 | $811.36 | MUNDRA SEA | FELIXSTOWE | SEA |
| 6 | Oct 2025 | UNLISTED BUYER | United Kingdom | Injection | 5.3K | VLS | $9.55 | $50K | MUNDRA SEA | FELIXSTOWE | SEA |
| 7 | Oct 2025 | UNLISTED BUYER | United Kingdom | Injection | 7.5K | VLS | $5.94 | $45K | MUNDRA SEA | FELIXSTOWE | SEA |
| 8 | Oct 2025 | UNLISTED BUYER | United Kingdom | Injection | 77 | VLS | $5.94 | $457.24 | MUNDRA SEA | FELIXSTOWE | SEA |
| 9 | Oct 2025 | UNLISTED BUYER | United Kingdom | Injection | 17 | VLS | $4.31 | $73.35 | AHMEDABAD AIR | LONDON - HEATHROW | AIR |
| 10 | Oct 2025 | UNLISTED BUYER | United Kingdom | Injection | 17 | VLS | $6.88 | $116.90 | AHMEDABAD AIR | LONDON - HEATHROW | AIR |
| 11 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 17 | VLS | $5.60 | $95.23 | AHMEDABAD AIR | MALTA | AIR |
| 12 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 17 | VLS | $5.63 | $95.65 | AHMEDABAD AIR | MALTA | AIR |
| 13 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 17 | VLS | $5.68 | $96.49 | AHMEDABAD AIR | MALTA | AIR |
| 14 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 17 | VLS | $5.79 | $98.39 | AHMEDABAD AIR | MALTA | AIR |
| 15 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 17 | VLS | $5.58 | $94.81 | AHMEDABAD AIR | MALTA | AIR |
| 16 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 17 | VLS | $5.60 | $95.23 | AHMEDABAD AIR | MALTA | AIR |
| 17 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 17 | VLS | $5.60 | $95.23 | AHMEDABAD AIR | MALTA | AIR |
| 18 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 17 | VLS | $5.60 | $95.23 | AHMEDABAD AIR | MALTA | AIR |
| 19 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 17 | VLS | $8.85 | $150.41 | AHMEDABAD AIR | MALTA | AIR |
| 20 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 21 | VLS | $8.81 | $185.01 | AHMEDABAD AIR | MALTA | AIR |
| 21 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 17 | VLS | $8.74 | $148.50 | AHMEDABAD AIR | MALTA | AIR |
| 22 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 17 | VLS | $8.81 | $149.77 | AHMEDABAD AIR | MALTA | AIR |
| 23 | Oct 2025 | UNLISTED BUYER | Poland | Injection | 904 | VLS | $6.46 | $6K | MUNDRA SEA | GDYNIA | SEA |
| 24 | Oct 2025 | UNLISTED BUYER | Poland | Injection | 77 | VLS | $6.46 | $497.43 | MUNDRA SEA | GDYNIA | SEA |
| 25 | Oct 2025 | UNLISTED BUYER | Poland | Injection | 1.1K | VLS | $6.44 | $7K | MUNDRA SEA | GDYNIA | SEA |
| 26 | Oct 2025 | UNLISTED BUYER | Poland | Injection | 77 | VLS | $6.44 | $495.57 | MUNDRA SEA | GDYNIA | SEA |
| 27 | Oct 2025 | UNLISTED BUYER | Poland | Injection | 1.4K | VLS | $6.43 | $9K | MUNDRA SEA | GDYNIA | SEA |
| 28 | Oct 2025 | UNLISTED BUYER | Poland | Injection | 77 | VLS | $6.43 | $495.15 | MUNDRA SEA | GDYNIA | SEA |
| 29 | Oct 2025 | UNLISTED BUYER | Poland | Injection | 903 | VLS | $6.40 | $6K | MUNDRA SEA | GDYNIA | SEA |
| 30 | Oct 2025 | UNLISTED BUYER | Poland | Injection | 77 | VLS | $6.40 | $492.66 | MUNDRA SEA | GDYNIA | SEA |
| 31 | Oct 2025 | UNLISTED BUYER | Poland | Injection | 1.1K | VLS | $9.99 | $11K | MUNDRA SEA | GDYNIA | SEA |
| 32 | Oct 2025 | UNLISTED BUYER | Poland | Injection | 85 | VLS | $9.99 | $849.47 | MUNDRA SEA | GDYNIA | SEA |
| 33 | Oct 2025 | BROCACEF NL:EU HUB | Netherlands | Injection | 903 | VLS | $6.17 | $6K | AHMEDABAD AIR | AMSTERDAM, SCHIPHOL | AIR |
| 34 | Oct 2025 | BROCACEF NL:EU HUB | Netherlands | Injection | 77 | VLS | $6.17 | $475.33 | AHMEDABAD AIR | AMSTERDAM, SCHIPHOL | AIR |
| 35 | Oct 2025 | BROCACEF NL:LOCAL | Netherlands | Injection | 4.9K | VLS | $9.52 | $47K | AHMEDABAD AIR | AMSTERDAM, SCHIPHOL | AIR |
| 36 | Oct 2025 | BROCACEF NL:LOCAL | Netherlands | Injection | 85 | VLS | $9.52 | $809.26 | AHMEDABAD AIR | AMSTERDAM, SCHIPHOL | AIR |
| 37 | Oct 2025 | ACCORD HEALTHCARE, SLU | Spain | Injection | 863 | VLS | $7.93 | $7K | AHMEDABAD AIR | BARCELONA | AIR |
| 38 | Oct 2025 | ACCORD HEALTHCARE, SLU | Spain | Injection | 85 | VLS | $7.93 | $674.33 | AHMEDABAD AIR | BARCELONA | AIR |
| 39 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 17 | VLS | $5.49 | $93.36 | AHMEDABAD AIR | MALTA | AIR |
| 40 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 17 | VLS | $8.56 | $145.52 | AHMEDABAD AIR | MALTA | AIR |
| 41 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 17 | VLS | $8.37 | $142.27 | AHMEDABAD AIR | MALTA | AIR |
| 42 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 17 | VLS | $8.38 | $142.47 | AHMEDABAD AIR | MALTA | AIR |
| 43 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 1.1K | VLS | $9.74 | $11K | MUNDRA SEA | ROTTERDAM | SEA |
| 44 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 85 | VLS | $9.74 | $828.10 | MUNDRA SEA | ROTTERDAM | SEA |
| 45 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 1.2K | VLS | $9.68 | $12K | MUNDRA SEA | ROTTERDAM | SEA |
| 46 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 85 | VLS | $9.68 | $823.16 | MUNDRA SEA | ROTTERDAM | SEA |
| 47 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 896 | TBS | $9.69 | $9K | MUNDRA SEA | ROTTERDAM | SEA |
| 48 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 85 | TBS | $9.69 | $823.64 | MUNDRA SEA | ROTTERDAM | SEA |
| 49 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 1.1K | VLS | $6.35 | $7K | MUNDRA SEA | ROTTERDAM | SEA |
| 50 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 77 | VLS | $6.35 | $489.17 | MUNDRA SEA | ROTTERDAM | SEA |
| 51 | Oct 2025 | UNLISTED BUYER | Austria | Solution | 904 | VLS | $6.45 | $6K | MUNDRA SEA | Genoa | SEA |
| 52 | Oct 2025 | UNLISTED BUYER | Austria | Solution | 77 | VLS | $6.45 | $496.37 | MUNDRA SEA | Genoa | SEA |
| 53 | Oct 2025 | UNLISTED BUYER | Austria | Injection | 1.0K | VLS | $9.89 | $10K | MUNDRA SEA | Genoa | SEA |
| 54 | Oct 2025 | UNLISTED BUYER | Austria | Injection | 85 | VLS | $9.89 | $840.53 | MUNDRA SEA | Genoa | SEA |
| 55 | Oct 2025 | EUROFINS BIOPHARMA PRODUCT TESTING | Hungary | Injection | 25 | NOS | $0.941 | $23.51 | AHMEDABAD AIR | BUDAPEST, | AIR |
| 56 | Oct 2025 | EUROFINS BIOPHARMA PRODUCT TESTING | Hungary | Injection | 25 | NOS | $0.941 | $23.51 | AHMEDABAD AIR | BUDAPEST, | AIR |
| 57 | Oct 2025 | EUROFINS BIOPHARMA PRODUCT TESTING | Hungary | Injection | 25 | NOS | $0.941 | $23.51 | AHMEDABAD AIR | BUDAPEST, | AIR |
| 58 | Oct 2025 | UNLISTED BUYER | Greece | Injection | 9 | VLS | $14.84 | $133.55 | AHMEDABAD AIR | ATHENS | AIR |
| 59 | Oct 2025 | UNLISTED BUYER | Greece | Injection | 17 | VLS | $7.45 | $126.65 | AHMEDABAD AIR | ATHENS | AIR |
| 60 | Oct 2025 | UNLISTED BUYER | France | Injection | 3.6K | VLS | $18.98 | $69K | AHMEDABAD AIR | PARIS - CHARLES DE G | AIR |
| 61 | Oct 2025 | UNLISTED BUYER | France | Injection | 61 | VLS | $18.98 | $1K | AHMEDABAD AIR | PARIS - CHARLES DE G | AIR |
| 62 | Oct 2025 | UNLISTED BUYER | Greece | Injection | 1.0K | VLS | $9.43 | $10K | MUNDRA SEA | Piraeus | SEA |
| 63 | Oct 2025 | UNLISTED BUYER | Greece | Injection | 85 | VLS | $9.43 | $801.44 | MUNDRA SEA | Piraeus | SEA |
| 64 | Oct 2025 | UNLISTED BUYER | Greece | Injection | 927 | VLS | $19.85 | $18K | MUNDRA SEA | Piraeus | SEA |
| 65 | Oct 2025 | UNLISTED BUYER | Greece | Injection | 61 | VLS | $19.85 | $1K | MUNDRA SEA | Piraeus | SEA |
| 66 | Oct 2025 | UNLISTED BUYER | Greece | Injection | 9 | VLS | $17.58 | $158.20 | AHMEDABAD AIR | ATHENS | AIR |
| 67 | Oct 2025 | UNLISTED BUYER | Greece | Injection | 9 | VLS | $17.64 | $158.76 | AHMEDABAD AIR | ATHENS | AIR |
| 68 | Oct 2025 | UNLISTED BUYER | Greece | Injection | 9 | VLS | $18.03 | $162.29 | AHMEDABAD AIR | ATHENS | AIR |
| 69 | Oct 2025 | UNLISTED BUYER | Greece | Injection | 9 | VLS | $17.47 | $157.27 | AHMEDABAD AIR | ATHENS | AIR |
| 70 | Oct 2025 | EUROFINS BIOPHARMA PRODUCT TESTING | Hungary | Injection | 25 | NOS | $0.813 | $20.34 | AHMEDABAD AIR | BUDAPEST, | AIR |
| 71 | Nov 2025 | UNLISTED BUYER | Greece | Injection | 9 | VLS | $13.12 | $118.04 | AHMEDABAD AIR | ATHENS | AIR |
| 72 | Nov 2025 | UNLISTED BUYER | Greece | Injection | 9 | VLS | $12.96 | $116.65 | AHMEDABAD AIR | ATHENS | AIR |
| 73 | Nov 2025 | UNLISTED BUYER | Greece | Injection | 9 | VLS | $13.19 | $118.75 | AHMEDABAD AIR | ATHENS | AIR |
| 74 | Nov 2025 | BROCACEF NL:EU HUB | Netherlands | Injection | 925 | VLS | $18.78 | $17K | MUNDRA SEA | Rotterdam | SEA |
| 75 | Nov 2025 | BROCACEF NL:EU HUB | Netherlands | Injection | 61 | VLS | $18.78 | $1K | MUNDRA SEA | Rotterdam | SEA |
| 76 | Nov 2025 | UNKNOWN BUYER | Netherlands | Injection | 925 | VLS | $18.78 | $17K | MUNDRA SEA | Rotterdam | SEA |
| 77 | Nov 2025 | UNKNOWN BUYER | Netherlands | Injection | 61 | VLS | $18.78 | $1K | MUNDRA SEA | Rotterdam | SEA |
| 78 | Nov 2025 | EUROFINS BIOPHARMA PRODUCT TESTING | Hungary | Injection | 25 | NOS | $0.887 | $22.19 | AHMEDABAD AIR | BUDAPEST, | AIR |
| 79 | Nov 2025 | UNLISTED BUYER | Austria | Injection | 928 | VLS | $19.22 | $18K | MUNDRA SEA | Genoa | SEA |
| 80 | Nov 2025 | UNLISTED BUYER | Austria | Injection | 61 | VLS | $19.22 | $1K | MUNDRA SEA | Genoa | SEA |
| 81 | Nov 2025 | UNLISTED BUYER | Greece | Injection | 17 | VLS | $4.87 | $82.86 | AHMEDABAD AIR | ATHENS | AIR |
| 82 | Nov 2025 | UNLISTED BUYER | United Kingdom | Injection | 2.7K | VLS | $5.82 | $16K | MUNDRA SEA | LONDON GATWAY PORT | SEA |
| 83 | Nov 2025 | UNLISTED BUYER | United Kingdom | Injection | 77 | VLS | $5.82 | $447.90 | MUNDRA SEA | LONDON GATWAY PORT | SEA |
| 84 | Nov 2025 | UNLISTED BUYER | Poland | Injection | 5.3K | VLS | $6.46 | $34K | MUNDRA SEA | Gdynia | SEA |
| 85 | Nov 2025 | UNLISTED BUYER | Poland | Injection | 77 | VLS | $6.46 | $497.13 | MUNDRA SEA | Gdynia | SEA |
| 86 | Nov 2025 | UNLISTED BUYER | Poland | Injection | 1.8K | VLS | $6.46 | $12K | MUNDRA SEA | Gdynia | SEA |
| 87 | Nov 2025 | UNLISTED BUYER | Poland | Injection | 77 | VLS | $6.46 | $497.13 | MUNDRA SEA | Gdynia | SEA |
| 88 | Nov 2025 | BROCACEF NL:EU HUB | Netherlands | 404 | VLS | $6.16 | $2K | MUNDRA SEA | Rotterdam | SEA | |
| 89 | Nov 2025 | BROCACEF NL:EU HUB | Netherlands | 77 | VLS | $6.16 | $474.45 | MUNDRA SEA | Rotterdam | SEA | |
| 90 | Nov 2025 | UNLISTED BUYER | United Kingdom | Injection | 17 | VLS | $4.61 | $78.44 | AHMEDABAD AIR | LONDON - HEATHROW | AIR |
| 91 | Nov 2025 | UNLISTED BUYER | Greece | Injection | 17 | VLS | $4.65 | $78.98 | AHMEDABAD AIR | ATHENS | AIR |
| 92 | Nov 2025 | UNLISTED BUYER | Greece | Injection | 17 | VLS | $4.65 | $78.98 | AHMEDABAD AIR | ATHENS | AIR |
| 93 | Nov 2025 | UNLISTED BUYER | Greece | Injection | 17 | VLS | $4.51 | $76.64 | AHMEDABAD AIR | ATHENS | AIR |
| 94 | Nov 2025 | UNLISTED BUYER | Greece | Injection | 17 | VLS | $4.54 | $77.17 | AHMEDABAD AIR | ATHENS | AIR |
| 95 | Dec 2025 | BROCACEF NL:EU HUB | Netherlands | Injection | 1.4K | VLS | $6.11 | $9K | MUNDRA SEA | Rotterdam | SEA |
| 96 | Dec 2025 | BROCACEF NL:EU HUB | Netherlands | Injection | 77 | VLS | $6.11 | $470.44 | MUNDRA SEA | Rotterdam | SEA |
| 97 | Dec 2025 | ACCORD UK | United Kingdom | Injection | 2.2K | VLS | $3.23 | $7K | MUNDRA SEA | Felixstowe | SEA |
| 98 | Dec 2025 | ACCORD UK | United Kingdom | Injection | 165 | VLS | $3.23 | $532.67 | MUNDRA SEA | Felixstowe | SEA |
| 99 | Dec 2025 | UNLISTED BUYER | United Kingdom | Injection | 4.6K | VLS | $5.76 | $27K | AHMEDABAD AIR | LONDON METROPOLITAN | AIR |
| 100 | Dec 2025 | UNLISTED BUYER | United Kingdom | Injection | 77 | VLS | $5.76 | $443.86 | AHMEDABAD AIR | LONDON METROPOLITAN | AIR |
| 101 | Dec 2025 | UNLISTED BUYER | United Kingdom | Injection | 55 | VLS | $2.59 | $142.33 | AHMEDABAD AIR | LONDON - HEATHROW | AIR |
| 102 | Dec 2025 | UNLISTED BUYER | Greece | Injection | 17 | VLS | $4.90 | $83.33 | AHMEDABAD AIR | ATHENS | AIR |
| 103 | Dec 2025 | UNLISTED BUYER | Greece | Injection | 51 | VLS | $2.60 | $132.36 | AHMEDABAD AIR | ATHENS | AIR |
| 104 | Dec 2025 | UNLISTED BUYER | Greece | Injection | 51 | VLS | $2.55 | $130.21 | AHMEDABAD AIR | ATHENS | AIR |
| 105 | Dec 2025 | EUROFINS BIOPHARMA PRODUCT TESTIN | Hungary | Injection | 25 | NOS | $1.01 | $25.37 | AHMEDABAD AIR | BUDAPEST, | AIR |
| 106 | Dec 2025 | EUROFINS BIOPHARMA PRODUCT TESTIN | Hungary | Injection | 25 | NOS | $1.01 | $25.37 | AHMEDABAD AIR | BUDAPEST, | AIR |
| 107 | Dec 2025 | BROCACEF NL : EU HUB | Netherlands | Injection | 975 | VLS | $0.034 | $33.46 | MUNDRA SEA | Rotterdam | SEA |
| 108 | Dec 2025 | BROCACEF NL : EU HUB | Netherlands | Injection | 165 | VLS | $0.034 | $5.66 | MUNDRA SEA | Rotterdam | SEA |
| 109 | Dec 2025 | UNLISTED BUYER | Greece | Injection | 9 | VLS | $17.31 | $155.76 | AHMEDABAD AIR | ATHENS | AIR |
| 110 | Dec 2025 | ACCORD HEALTHCARE FRANCE SAS | Netherlands | Injection | 940 | VLS | $0.033 | $30.68 | MUNDRA SEA | Rotterdam | SEA |
| 111 | Dec 2025 | ACCORD HEALTHCARE FRANCE SAS | Netherlands | Injection | 145 | VLS | $0.033 | $4.73 | MUNDRA SEA | Rotterdam | SEA |
| 112 | Dec 2025 | BROCACEF NL : EU HUB | Netherlands | Injection | 1.0K | VLS | $0.061 | $61.59 | MUNDRA SEA | Rotterdam | SEA |
| 113 | Dec 2025 | BROCACEF NL : EU HUB | Netherlands | Injection | 77 | VLS | $0.061 | $4.72 | MUNDRA SEA | Rotterdam | SEA |
| 114 | Dec 2025 | BROCACEF NL : LOCAL | Netherlands | Injection | 2.3K | VLS | $0.060 | $137.81 | MUNDRA SEA | Rotterdam | SEA |
| 115 | Dec 2025 | BROCACEF NL : LOCAL | Netherlands | Injection | 77 | VLS | $0.060 | $4.61 | MUNDRA SEA | Rotterdam | SEA |
| 116 | Dec 2025 | UNLISTED BUYER | United Kingdom | Injection | 8.0K | VLS | $0.050 | $402.10 | MUNDRA SEA | Felixstowe | SEA |
| 117 | Dec 2025 | UNLISTED BUYER | United Kingdom | Injection | 77 | VLS | $0.050 | $3.86 | MUNDRA SEA | Felixstowe | SEA |
| 118 | Dec 2025 | UNLISTED BUYER | Poland | Injection | 1.5K | VLS | $0.145 | $221.16 | MUNDRA SEA | Gdynia | SEA |
| 119 | Dec 2025 | UNLISTED BUYER | Poland | Injection | 145 | VLS | $0.145 | $21.03 | MUNDRA SEA | Gdynia | SEA |
| 120 | Dec 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 2.3K | VLS | $6.38 | $15K | MUNDRA SEA | Piraeus | SEA |
| 121 | Dec 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 77 | VLS | $6.38 | $490.94 | MUNDRA SEA | Piraeus | SEA |
| 122 | Dec 2025 | UNLISTED BUYER | Austria | Solution | 2.3K | VLS | $6.54 | $15K | MUNDRA SEA | Genoa | SEA |
| 123 | Dec 2025 | UNLISTED BUYER | Austria | Solution | 77 | VLS | $6.54 | $503.41 | MUNDRA SEA | Genoa | SEA |
| 124 | Dec 2025 | UNLISTED BUYER | France | Injection | 1.4K | VLS | $6.08 | $9K | AHMEDABAD AIR | PARIS - CHARLES DE G | AIR |
| 125 | Dec 2025 | UNLISTED BUYER | France | Injection | 77 | VLS | $6.08 | $467.92 | AHMEDABAD AIR | PARIS - CHARLES DE G | AIR |
| SUPPLIER #2 — FRESENIUS KABI ONCOLOGY LTD · 4 shipments · $62K | |||||||||||
| 126 | Nov 2025 | EUROFINS BIOPHARMA PRODUCT TESTING | Hungary | Injection | 104 | VLS | $5.25 | $545.98 | DELHI AIR | BUDAPEST, | AIR |
| 127 | Nov 2025 | FRESENIUS KABI DEUTSCHLAND GMBH | Germany | Injection | 6.1K | NOS | $7.22 | $44K | BADDI ICD | HAMBURG | ICD |
| 128 | Dec 2025 | FRESENIUS KABI DEUTSCHLAND GMBH | Germany | Injection | 1.0K | NOS | $7.22 | $7K | BADDI ICD | HAMBURG | ICD |
| 129 | Dec 2025 | FRESENIUS KABI DEUTSCHLAND GMBH | Germany | Injection | 1.4K | NOS | $7.24 | $10K | BADDI ICD | HAMBURG | ICD |
| SUPPLIER #3 — NAPROD LIFE SCIENCES PVT LTD · 1 shipments · $9K | |||||||||||
| 130 | Dec 2025 | DITA ESTFARM SRL | Moldova | Injection | 3.6K | VLS | $2.50 | $9K | MUMBAI AIR (SAHAR) | CHISINAU | AIR |
| SUPPLIER #4 — RUS MED EXPORTS PVT LTD · 1 shipments · $8K | |||||||||||
| 131 | Oct 2025 | RUS MED EXPORTS FZE | Russia | Tablet | 3.0K | VLS | $2.83 | $8K | HYDERABAD AIR | MOSCOW DOMODEDOVO | AIR |
| SUPPLIER #5 — BRUCK PHARMA PVT LTD · 1 shipments · $1K | |||||||||||
| 132 | Dec 2025 | UNLISTED BUYER | Bosnia and Herzegovina | Injection | 400 | NOS | $2.53 | $1K | MUMBAI AIR (SAHAR) | SARAJEVO | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
6 countries · 8 shipments · $66K · 7 Indian suppliers · 6 buyers
SHIPMENTS
8
USD
$66K
COUNTRIES
6
SUPPLIERS
7
BUYERS
6
HHI
4,315
concentrated
Top 6 destination countries in Americas
1
Brazil (61.4%)
$41K
2
Colombia (25.3%)
$17K
3
Guatemala (13.0%)
$9K
4
Mexico (0.3%)
$222.27
5
Trinidad and Tobago (0.0%)
$2.99
6
Jamaica (0.0%)
$0.239
Top 7 Indian suppliers into Americas
1
INTAS PHARMACEUTICALS LTD
$41K
2
NAPROD LIFE SCIENCES PVT LTD
$12K
3
CELON LABORATORIES PVT LTD
$9K
4
SAKAR HEALTHCARE LTD
$5K
5
VAMA HEALTH WORLD LLP
$222.27
6
GETWELL PHARMA INDIA PVT LTD
$2.99
7
DISTINCT IMPEX PVT LTD
$0.239
Top 5 Americas importers
1
AL PHARMA SAS · Colombia
$12K
2
SEVEN PHARMA GUATEMALA SA · Guatemala
$9K
3
ADVANCE SCIENTIFIC DE COLOMBIA S.A · Colombia
$5K
4
AS PER INVOICE MEXICO · Mexico
$222.27
5
SUNCREST INTERNATIONAL LTD · Trinidad and Tobago
$2.99
Top 1 dosage forms
1
Injection
$66K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $9K | $9K |
| Nov | 3 | $12K | $4K |
| Dec | 4 | $45K | $11K |
Shipment register · 8 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — INTAS PHARMACEUTICALS LTD · 1 shipments · $41K | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Brazil | Injection | 16.8K | VLS | $2.42 | $41K | MUNDRA SEA | Santos | SEA |
| SUPPLIER #2 — NAPROD LIFE SCIENCES PVT LTD · 1 shipments · $12K | |||||||||||
| 2 | Nov 2025 | AL PHARMA SAS | Colombia | Injection | 3.3K | VLS | $3.59 | $12K | MUMBAI AIR (SAHAR) | BOGOTA | AIR |
| SUPPLIER #3 — CELON LABORATORIES PVT LTD · 1 shipments · $9K | |||||||||||
| 3 | Oct 2025 | SEVEN PHARMA GUATEMALA SA | Guatemala | Injection | 2.0K | NOS | $4.28 | $9K | HYDERABAD AIR | GUATEMALA CITY | AIR |
| SUPPLIER #4 — SAKAR HEALTHCARE LTD · 1 shipments · $5K | |||||||||||
| 4 | Dec 2025 | ADVANCE SCIENTIFIC DE COLOMBIA S.A | Colombia | Injection | 1.0K | NOS | $4.59 | $5K | AHMEDABAD AIR | BOGOTA | AIR |
| SUPPLIER #5 — VAMA HEALTH WORLD LLP · 1 shipments · $222.27 | |||||||||||
| 5 | Dec 2025 | AS PER INVOICE MEXICO | Mexico | Injection | 37 | NOS | $6.01 | $222.27 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #6 — GETWELL PHARMA INDIA PVT LTD · 2 shipments · $2.99 | |||||||||||
| 6 | Nov 2025 | SUNCREST INTERNATIONAL LTD | Trinidad and Tobago | Injection | 2 | NOS | $0.499 | $0.998 | DELHI AIR | PORT OF SPAIN, PIARC | AIR |
| 7 | Nov 2025 | SUNCREST INTERNATIONAL LTD | Trinidad and Tobago | Injection | 2 | NOS | $0.998 | $2.00 | DELHI AIR | PORT OF SPAIN, PIARC | AIR |
| SUPPLIER #7 — DISTINCT IMPEX PVT LTD · 1 shipments · $0.239 | |||||||||||
| 8 | Dec 2025 | UNLISTED BUYER | Jamaica | Injection | 10 | NOS | $0.024 | $0.239 | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 42 Indian cytarabine exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped cytarabine in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LTD | AHMEDABAD | 126 | $625K | Injection, Solution | Europe, Americas |
| 2 | FRESENIUS KABI ONCOLOGY LTD | NEW DELHI | 12 | $514K | Solution, Injection | Africa, Europe |
| 3 | UNITED BIOTECH PVT LTD | NEW DELHI | 12 | $40K | Injection | Asia |
| 4 | GLS PHARMA LTD | RANGARDDY TELANGALA | 3 | $23K | Vial | Asia |
| 5 | NAPROD LIFE SCIENCES PVT LTD | MUMBAI | 2 | $21K | Injection | Americas, Europe |
| 6 | ZIL PHARMA | MUMBAI | 1 | $13K | Injection | Asia |
| 7 | CELON LABORATORIES PVT LTD | HYDERABAD TELANGANA | 1 | $9K | Injection | Americas |
| 8 | RUS MED EXPORTS PVT LTD | MUMBAI | 1 | $8K | Tablet | Europe |
| 9 | GETWELL PHARMA INDIA PVT LTD | GURGAON | 4 | $7K | Injection | Americas, Asia |
| 10 | ZUVIUS LIFESCIENCES PVT LTD | GHATKOPAR (E) | 9 | $6K | Injection | Asia, Africa |
| 11 | SAKAR HEALTHCARE LTD | AHMEDABAD | 1 | $5K | Injection | Americas |
| 12 | RESCUERS LIFE SCIENCES LTD | NALAGARH ROAD BADDI | 4 | $5K | Injection | Asia |
| 13 | VHB MEDI SCIENCES LTD | UDHAMSINGH NAGAR | 1 | $4K | Injection | Asia |
| 14 | HEET HEALTHCARE PVT LTD | AHMEDABAD | 6 | $3K | Injection | Asia |
| 15 | AASHVI PHARMACEUTICALS PVT LTD | Ahmedabad | 1 | $3K | Injection | Africa |
| 16 | BRUCK PHARMA PVT LTD | NANI | 3 | $2K | Injection | Asia, Europe |
| 17 | PNT PHARMA | MUMBAI | 1 | $2K | product | Africa |
| 18 | MATHI ASSOCIATES | MUMBAI | 2 | $1K | Injection | Africa |
| 19 | WELLKIND PHARMACEUTICAL PVT LTD | MUZAFFARANAGAR | 1 | $1K | Injection | Africa |
| 20 | PLEASANT EXPORTS | CHENNAI | 2 | $1K | Injection | Asia |
| 21 | RMPL PHARMA LLP | MUMBAI | 4 | $1K | Injection | Asia, Africa |
| 22 | DROPS PHARMA PVT LTD | HOSDURG | 4 | $1K | Injection | Asia |
| 23 | LEOWIN HEALTHCARE LLP | GANDHINAGAR | 4 | $1K | Injection | Asia |
| 24 | J.A. UNITED EXPORTS PVT LTD | VASHI | 2 | $703.11 | Injection | Asia |
| 25 | MEDWISE OVERSEAS PVT LTD | AHMEDABAD | 1 | $596.55 | Injection | Asia |
| 26 | SANSKRUTI PHARMA | SURAT | 6 | $447.75 | Injection | Africa |
| 27 | R.S. SURGIPHARM PVT LTD | AHMEDABAD | 2 | $347.44 | Injection | Africa |
| 28 | VAMA HEALTH WORLD LLP | Mumbai | 2 | $223.70 | Injection | Africa, Americas |
| 29 | MATOSHREE HEALTH CARE PVT LTD | THAKURDWAR MUMBAI | 1 | $159.25 | Injection | Africa |
| 30 | SAYAR LIFE-CARE | Chennai | 1 | $143.17 | Vial | Africa |
| 31 | JMB PHARMACEUTICALS PVT LTD | MUMBAI | 3 | $97.09 | Injection | Asia |
| 32 | AMARI TRADE ALLIANCE LLP | MUMBAI | 3 | $86.99 | Injection | Africa, Asia |
| 33 | DM WORLDWIDE TRADING | MAHESANA | 1 | $74.25 | Injection | Africa |
| 34 | BARAKAH BIOHEALTH LLP | TIRUPPUR | 1 | $63.91 | Injection | Africa |
| 35 | KINGS GLOBAL BIOTECH LTD | PUNE | 1 | $26.21 | Injection | Asia |
| 36 | BIOZENTA LIFESCIENCE PVT LTD | Una | 2 | $16.26 | Injection | Africa |
| 37 | AANYA GLOBAL | Mumbai | 2 | $14.12 | Injection, Vial | Asia |
| 38 | GENEX PHARMA | MUMBAI MAHARASHTRA | 1 | $3.74 | Injection | Asia |
| 39 | M T MADON EXPORTS | MUMBAI | 1 | $2.75 | Injection | Africa |
| 40 | VAMA LIFECARE PVT LTD | MUMBAI | 2 | $1.21 | Injection | Asia |
| 41 | DISTINCT IMPEX PVT LTD | MUMBAI | 1 | $0.239 | Injection | Americas |
| 42 | MCARE IMPEX PVT LTD | Aligarh | 1 | $0.0000 | Injection | Asia |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 49 global cytarabine importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian cytarabine in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | FRESENIUS KABI SOUTH AFRICA (PTY) | South Africa | 3 | $350K | FRESENIUS KABI ONCOL… | Solution, Injection |
| 2 | FRESENIUS KABI DEUTSCHLAND GMBH | Germany | 3 | $62K | FRESENIUS KABI ONCOL… | Injection |
| 3 | FRESENIUS KABI MALAYSIA SDN BHD | Malaysia | 1 | $58K | FRESENIUS KABI ONCOL… | Injection |
| 4 | BROCACEF NL:LOCAL | Netherlands | 2 | $47K | INTAS PHARMACEUTICAL… | Injection |
| 5 | BROCACEF NL:EU HUB | Netherlands | 8 | $37K | INTAS PHARMACEUTICAL… | Injection |
| 6 | FRESENIUS KABI (THAILAND) LTD | Thailand | 1 | $25K | FRESENIUS KABI ONCOL… | Injection |
| 7 | ALFWASEL FOR GENERAL TRADING | Yemen | 3 | $23K | GLS PHARMA LTD | Vial |
| 8 | PEOPLES BANK | Sri Lanka | 1 | $18K | UNITED BIOTECH PVT LTD | Injection |
| 9 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | 2 | $15K | INTAS PHARMACEUTICAL… | Injection |
| 10 | KAZBIOTECH LLP | Kazakhstan | 3 | $13K | UNITED BIOTECH PVT LTD | Injection |
| 11 | AL PHARMA SAS | Colombia | 1 | $12K | NAPROD LIFE SCIENCES… | Injection |
| 12 | DITA ESTFARM SRL | Moldova | 1 | $9K | NAPROD LIFE SCIENCES… | Injection |
| 13 | SEVEN PHARMA GUATEMALA SA | Guatemala | 1 | $9K | CELON LABORATORIES P… | Injection |
| 14 | FRESENIUS KABI SOUTH AFRICA (PTY) L | South Africa | 1 | $8K | FRESENIUS KABI ONCOL… | Injection |
| 15 | RUS MED EXPORTS FZE | Russia | 1 | $8K | RUS MED EXPORTS PVT … | Tablet |
| 16 | ACCORD UK | United Kingdom | 2 | $8K | INTAS PHARMACEUTICAL… | Injection |
| 17 | ACCORD HEALTHCARE, SLU | Spain | 2 | $8K | INTAS PHARMACEUTICAL… | Injection |
| 18 | THE ESSES PHARMACY (PRIVATE)LTD | Sri Lanka | 2 | $7K | GETWELL PHARMA INDIA… | Injection |
| 19 | ADVANCE SCIENTIFIC DE COLOMBIA S.A | Colombia | 1 | $5K | SAKAR HEALTHCARE LTD | Injection |
| 20 | ETEMED MOSLEH LTD | Afghanistan | 4 | $5K | RESCUERS LIFE SCIENC… | Injection |
| 21 | OUBARI-HABBOUSH PHARMA | Lebanon | 1 | $4K | VHB MEDI SCIENCES LTD | Injection |
| 22 | THEIKDI MAUG CO LTD | Myanmar | 2 | $4K | ZUVIUS LIFESCIENCES … | Injection |
| 23 | NIKHIL PHARMA PVT LTD | Nepal | 4 | $3K | UNITED BIOTECH PVT LTD | Injection |
| 24 | SAK CAM PHARMA CO LTD | Cambodia | 1 | $3K | UNITED BIOTECH PVT LTD | Injection |
| 25 | ATCO PHARMA INTERNATIONAL PVT LTD | Pakistan | 1 | $3K | FRESENIUS KABI ONCOL… | Injection |
| 26 | IMPERIAL PHOENIX CO LTD | Myanmar | 1 | $2K | ZUVIUS LIFESCIENCES … | Injection |
| 27 | TO THE | Rwanda | 1 | $2K | PNT PHARMA | product |
| 28 | PHARMACHEIME LTD | Malawi | 2 | $1K | MATHI ASSOCIATES | Injection |
| 29 | NEW AFRICA SOFTWARE SOLUTION LTD | Ghana | 1 | $1K | WELLKIND PHARMACEUTI… | Injection |
| 30 | THE ESSES PHARMACY (PVT) LTD | Sri Lanka | 2 | $1K | PLEASANT EXPORTS | Injection |
| 31 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | 2 | $703.11 | J.A. UNITED EXPORTS … | Injection |
| 32 | EUROFINS BIOPHARMA PRODUCT TESTING | Hungary | 6 | $659.05 | FRESENIUS KABI ONCOL… | Injection |
| 33 | DOMAKS INVESTMENT LTD | Nigeria | 4 | $562.79 | ZUVIUS LIFESCIENCES … | Injection |
| 34 | MEDIMART DRUG STORE | United Arab Emirates | 1 | $342.79 | DROPS PHARMA PVT LTD | Injection |
| 35 | AS PER INVOICE MEXICO | Mexico | 1 | $222.27 | VAMA HEALTH WORLD LLP | Injection |
| 36 | MINISTRY OF HEALTH ( CLAUDE JULIEN | Seychelles | 1 | $143.17 | SAYAR LIFE-CARE | Vial |
| 37 | BROCACEF NL : LOCAL | Netherlands | 2 | $142.42 | INTAS PHARMACEUTICAL… | Injection |
| 38 | BROCACEF NL : EU HUB | Netherlands | 4 | $105.43 | INTAS PHARMACEUTICAL… | Injection |
| 39 | DALIAN CHAOHONGSUPPLY CHAIN MANAGEM | China | 1 | $97.09 | JMB PHARMACEUTICALS … | Injection |
| 40 | ABU AHMED | Kenya | 1 | $71.69 | AMARI TRADE ALLIANCE… | Injection |
| 41 | EUROFINS BIOPHARMA PRODUCT TESTIN | Hungary | 2 | $50.74 | INTAS PHARMACEUTICAL… | Injection |
| 42 | ACCORD HEALTHCARE FRANCE SAS | Netherlands | 2 | $35.41 | INTAS PHARMACEUTICAL… | Injection |
| 43 | TO THE IMPORT MANAGER | United Arab Emirates | 1 | $26.21 | KINGS GLOBAL BIOTECH… | Injection |
| 44 | ABU ABDU | Turkey | 2 | $15.30 | AMARI TRADE ALLIANCE… | Injection |
| 45 | SUNCREST INTERNATIONAL LTD | Trinidad and Tobago | 2 | $2.99 | GETWELL PHARMA INDIA… | Injection |
| 46 | MOHAMED AHEMED MOHAMUD | Somalia | 1 | $2.75 | M T MADON EXPORTS | Injection |
| 47 | AS PER INVOICE GHANA | Ghana | 1 | $1.42 | VAMA HEALTH WORLD LLP | Injection |
| 48 | AS PER INVOICE SRI LANKA | Sri Lanka | 2 | $1.21 | VAMA LIFECARE PVT LTD | Injection |
| 49 | BAWABAT ALDAWA MEDICINEES STORE LLC | United Arab Emirates | 1 | $0.0000 | MCARE IMPEX PVT LTD | Injection |
This report covers 239 2025-Q4 Cytarabine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/cytarabine
Talk to our trade analyst
Need a custom cytarabine report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/cytarabine
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Cytarabine product page
Live data, supplier directory, price trends, and trade route analysis